JMP starts Novadaq at market outperform

JMP Securities has initiated coverage of Novadaq Technologies (TSX:NDQ) with an “outperform” rating and 12-month price target of $7. The stock closed at $4.72 on Monday SPY is a breakthrough imaging system that allows surgeons to visualize blood flow and perfusion in real-time. The company has established partnerships with LifeCell and Intuitive Surgical, which “in [...]

BioSante’s LibiGel is Last Woman Standing

At BioSante Pharmaceuticals (NASDAQ:BPAX), they like to say that their LibiGel transdermal treatment for female sexual dysfunction (FSD) is the “Last Woman Standing”. That’s because Boehringer Ingelheim and Warner Chilcott  have each pulled the plug on their competing FSD treatments for menopausal and pre-menopausal women. “LibiGel is now the only compound in active late-stage clinical development [...]

JMP starts BioSante at market outperform

JMP Securities has initiated coverage of BioSante Pharmaceuticals (NASDAQ:BPAX) with a “market outperform” rating and price target of $5, saying the drug developer is an “underfollowed and undervalued microcap company, with a late-stage development asset that has better than average clinical risk.” The stock was changing hands at $1.84 midway through the Wednesday session. Analyst [...]

YM prices $40 million public offering

YM BioSciences (TSX:YM; AMEX:AMI) has priced a public offering of 25 million common shares at $1.60 a share to yield gross proceeds of $40 million for its drug development activities and general corporate purposes. The offering is expected to close on Dec. 17. The company also granted underwriters a 30-day option to purchase up to [...]

DiagnoCure retains JMP Securities

DiagnoCure (TSX:CUR) has retained financial advisors JMP Securities to assist in determining the best option to drive the growth of its U.S.-based subsidiary, DiagnoCure Oncology Laboratories. “We are very excited to be partnering with JMP, and we are confident that their expertise will help us determine the most effective method to roll out our colorectal [...]